Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) - Hänggi, Daniel; Macdonald, Robert Loch (Stroke, 2017)
Gesehen am 04.10.2018